RCEL

#3381
Avita Medical, Inc. - Common Stock
4.3 3 USD
-1.37%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
4.33
4.33
년간 변동
3.22
7.12
일일 변동
-1.37%
월간 변동
+1.64%
6달 변화
+17.03%
년간 변동율
-25.34%
이전 종가
4.3 9
Open
4.3 3
저가
4.3 3
High
4.3 3
양
19
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 133.26 M
  • Employee 226
  • Founded 1999
  • CEO James Corbett
  • Website www.avitamedical.com
  • Headquarter Delaware, United States
  • FIGI BBG00TD18T43
  • Industry 의료 기기
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-1.98
주가매출액비율
1.34

Avita Medical, Inc. - Common Stock

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

뉴스